Article
An Optimized CRISPR/Cas12a Assay to Facilitate the BRAF V600E Mutation Detection.
Journal of clinical laboratory analysis - 1 Nov 2024
Etemadzadeh Azadeh, Salehipour Pouya, Motlagh Fatemeh Movahedi, Khalifeh Masoomeh, Asadbeigi Adnan, Tabrizi Mina, Shirkouhi Reza, Modarressi Mohammad Hossein
Abstract excerpt
BACKGROUND: Accurate detection of the BRAF V600E (1799T > A) mutation status can significantly contribute to selecting an optimal therapeutic strategy for diverse cancer types. CRISPR-based diagnostic platforms exhibit simple programming, cost-effectiveness, high sensitivity, and high specificity...
Topics
- Proto-Oncogene Proteins B-raf
- Humans
- CRISPR-Cas Systems
- Mutation
- DNA Mutational Analysis
- Limit of Detection
- Neoplasms
